The Supply Chain Act in Germany, which has been in effect for companies with 1,000 to 3,000 employees since early 2024, is perceived as complex and burdensome. Companies like Biotest are grappling with compliance costs and the implementation of human rights protocols. Experts suggest that while the act aims to improve human rights in supply chains, its bureaucratic requirements could be streamlined. With 5,200 companies required to comply, the industry is awaiting clarity on future operations amid changes anticipated in a forthcoming European supply chain law.

Source